Publications

Clinical nuclear medicine

18F-FDG PET/CT During Neoadjuvant Targeted Therapy in Prior Unresectable Stage III Melanoma Patients: Can (Early) Metabolic Imaging Predict Histopathologic Response or Recurrence?

BJU international

Cytoreductive nephrectomy and exposure to sunitinib - a post hoc analysis of the Immediate Surgery or Surgery After Sunitinib Malate in Treating Patients With Metastatic Kidney Cancer (SURTIME) trial.

Retinal cases & brief reports

BILATERAL SEROUS RETINAL DETACHMENT AND UVEITIS ASSOCIATED WITH PEMBROLIZUMAB TREATMENT IN METASTATIC MELANOMA.

Cell reports. Medicine

TIL classified to memory state are correlated with response to immune checkpoint blockade.

21-06-2022

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Prospective Cardiovascular Surveillance of Immune Checkpoint Inhibitor-Based Combination Therapy in Patients With Advanced Renal Cell Cancer: Data From the Phase III JAVELIN Renal 101 Trial.

10-06-2022

European urology oncology

Surgical Safety of Deferred Cytoreductive Nephrectomy Following Pretreatment with Immune Checkpoint Inhibitor-based Dual Combination Therapy.

01-06-2022

Nature reviews. Clinical oncology

COVID-19 vaccines in patients with cancer: immunogenicity, efficacy and safety.

01-06-2022

Nature medicine

Personalized response-directed surgery and adjuvant therapy after neoadjuvant ipilimumab and nivolumab in high-risk stage III melanoma: the PRADO trial.

01-06-2022

European journal of nuclear medicine and molecular imaging

[¹⁸F]FDG-PET accurately identifies pathological response early upon neoadjuvant immune checkpoint blockade in head and neck squamous cell carcinoma.

01-05-2022

European journal of cancer (Oxford, England : 1990)

Response to immune checkpoint inhibitors in acral melanoma: A nationwide cohort study.

01-05-2022

British journal of cancer

Correction: First-line BRAF/MEK inhibitors versus anti-PD-1 monotherapy in BRAF^V600-mutant advanced melanoma patients: a propensity-matched survival analysis.

01-05-2022

American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting

Neoadjuvant Immunotherapy: Leveraging the Immune System to Treat Early-Stage Disease.

01-04-2022

International journal of cancer

The unfavorable effects of COVID-19 on Dutch advanced melanoma care.

01-03-2022

Clinical cancer research : an official journal of the American Association for Cancer Research

From Basic Science to Clinical Translation in Kidney Cancer: A Report from the Second Kidney Cancer Research Summit.

01-03-2022

Clinical cancer research : an official journal of the American Association for Cancer Research

Association of Neutrophil-to-Lymphocyte Ratio with Efficacy of First-Line Avelumab plus Axitinib vs. Sunitinib in Patients with Advanced Renal Cell Carcinoma Enrolled in the Phase 3 JAVELIN Renal 101 Trial.

15-02-2022

Annals of oncology : official journal of the European Society for Medical Oncology

Investigation of sex and gender differences in oncology gains momentum: ESMO announces the launch of a Gender Medicine Task Force.

Journal of the European Academy of Dermatology and Venereology : JEADV

Survival of stage IV melanoma in Belgium and the Netherlands.

ESMO open

The impact of COVID-19 on oncology professionals-one year on: lessons learned from the ESMO Resilience Task Force survey series.

Prostate cancer and prostatic diseases

Integrated analysis of pain, health-related quality of life, and analgesic use in patients with metastatic castration-resistant prostate cancer treated with Radium-223.

International journal of cancer

Discontinuation of anti-PD-1 monotherapy in advanced melanoma-Outcomes of daily clinical practice.

15-01-2022

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Long-Term Outcomes With Nivolumab Plus Ipilimumab or Nivolumab Alone Versus Ipilimumab in Patients With Advanced Melanoma.

10-01-2022

European journal of cancer (Oxford, England : 1990)

Life-prolonging treatment restrictions and outcomes in patients with cancer and COVID-19: an update from the Dutch Oncology COVID-19 Consortium.

01-01-2022

Annals of oncology : official journal of the European Society for Medical Oncology

⁸⁹Zr-pembrolizumab imaging as a non-invasive approach to assess clinical response to PD-1 blockade in cancer.

01-01-2022

European urology open science

Primary Renal Tumour Response in Patients Treated with Nivolumab and Ipilimumab for Metastatic Renal Cell Carcinoma: Real-world Data Assessment.

01-01-2022

Nature communications

Neoadjuvant immunotherapy with nivolumab and ipilimumab induces major pathological responses in patients with head and neck squamous cell carcinoma.

22-12-2021

The Lancet. Oncology

mRNA-1273 COVID-19 vaccination in patients receiving chemotherapy, immunotherapy, or chemoimmunotherapy for solid tumours: a prospective, multicentre, non-inferiority trial.

Immuno-oncology technology

New milestones for IOTECH in 2022.

ESMO open

Female leadership in oncology-has progress stalled? Data from the ESMO W4O authorship and monitoring studies.

ESMO open

Trends in survival and costs in metastatic melanoma in the era of novel targeted and immunotherapeutic drugs.

The Lancet. Oncology

Immunotherapy for cancer treatment during pregnancy.